Endoglin (CD105) expression in neurofibromatosis type 2 vestibular schwannoma.
Gino MarioniLorenzo NicolèDiego CazzadorChiara PavoneDomenico D'AvellaAlessandro MartiniAntonio MazzoniElisabetta ZanolettiPublished in: Head & neck (2019)
Further investigations are needed to ascertain the feasibility of (a) measuring circulating endoglin levels to monitor tumor growth rate and (b) targeting tumor neoangiogenesis with anti-endoglin approaches in NF2-associated VS.